Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA6 | P23280 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9280225 | 0.87 | CYP2C19 (0.48) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL10537772 | 0.76 | LMNA (0.33) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL11905533 | 0.73 | CA12 (0.46) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL7802925 | 0.72 | CYP2C9 (0.33) | CYP2C9CYP2C19TDP1 | |
| Alcohol SCHEMBL9008042 | 0.71 | CA12 (0.39) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL10506433 | 0.71 | TDP1 (0.39) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL28316132 | 0.69 | CA12 (0.46) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL102185 | 0.69 | CA12 (0.46) | CYP2C9CYP2C19TDP1CA12CA6 | |
| Trimethylammonium SCHEMBL27795493 | 0.69 | CYP2C19 (0.54) | CYP2C9CYP2C19TDP1CA12CA6 | |
| SCHEMBL8987402 | 0.69 | CA12 (0.41) | CYP2C9CYP2C19TDP1CA12CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1029 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10758490-B2 | Nanocapsules containing microemulsions | LIPOTEC, S.A. (ES) | 2020-09-01 | — | — | US | claimed |
| US-20200115662-A1 | POLYELECTROLYTE COMPLEXES | CLOROX CO (US) | 2020-04-16 | — | — | US | claimed |
| US-10563156-B2 | Polyelectrolyte complexes | THE CLOROX COMPANY (US) | 2020-02-18 | — | — | US | claimed |
| US-20190136163-A1 | POLYELECTROLYTE COMPLEXES | CLOROX CO (US) | 2019-05-09 | — | — | US | claimed |
| US-10208275-B2 | Polyelectrolyte complexes | THE CLOROX COMPANY (US) | 2019-02-19 | — | — | US | claimed |
| US-20180320115-A1 | POLYELECTROLYTE COMPLEXES | CLOROX CO (US) | 2018-11-08 | — | — | US | claimed |
| US-10066196-B2 | Polyelectrolyte complexes | THE CLOROX COMPANY (US) | 2018-09-04 | — | — | US | claimed |
| EP-2536815-B1 | USE OF LIPOSOMES FOR THE TREATMENT OF TEXTILE MATERIALS | LIPOTEC SA (ES) | 2018-07-11 | — | — | EP | claimed |
| US-20180023044-A1 | POLYELECTROLYTE COMPLEXES | THE CLOROX COMPANY (US) | 2018-01-25 | — | — | US | claimed |
| EP-3272398-A1 | LIPID NANOPARTICLE CAPSULES | Lipotec S.A. (ES) | 2018-01-24 | — | — | EP | claimed |
| US-6878379-B2 | Cosmetic preparations | COGNIS DEUTSCHLAND GMBH & CO., KG (DE) | 2005-04-12 | — | — | US | claimed |
| US-20050025732-A1 | Cosmetic preparations | ANSMANN ACHIM (DE) | 2005-02-03 | — | — | US | claimed |
| US-20050025733-A1 | Pearlescent conditioning shampoos containing long chain dialkyl ether or ester, cationic polymer and betaine; cleaning and degreasing; mild to skin and hair; storage stability; antistatic effect | ANSMANN ACHIM (DE) | 2005-02-03 | — | — | US | claimed |
| EP-0941060-B1 | COSMETIC PREPARATIONS | COGNIS DEUTSCHLAND GMBH (DE) | 2003-04-02 | — | — | EP | claimed |
| EP-0776657-B1 | Cosmetic and/or pharmaceutical emulsions | COGNIS DEUTSCHLAND GMBH (DE) | 2003-03-26 | — | — | EP | claimed |
| EP-1189990-B1 | UTILIZATION OF EMULSIFIERS | COGNIS DEUTSCHLAND GMBH (DE) | 2003-02-26 | — | — | EP | claimed |
| US-20020055451-A1 | Detergent tablets | KISCHKEL DITMAR (DE) | 2002-05-09 | — | — | US | claimed |
| US-6365168-B1 | PEARLESCENT COMPOSITION COMPRISING DIALKYL ETHER, CATIONIC POLYMER, AND ALKYL AND/OR ALKENYL OLIGOGLYCOSIDE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-04-02 | — | — | US | claimed |
| US-20020012686-A1 | Cosmetic formulations | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2002-01-31 | — | — | US | claimed |
| EP-0768863-B1 | COSMETICS AGENTS | HENKEL KGAA (DE) | 1999-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050025733-A1 | Pearlescent conditioning shampoos containing long chain dialkyl ether or ester, cationic polymer and betaine; cleaning and degreasing; mild to skin and hair; storage stability; antistatic effect | DEGS1, POLR1C, BCL2L10 | CYP2C9 3443/4885CYP2C19 4073/4885TDP1 2664/4885 |
| US-20020012686-A1 | Cosmetic formulations | DEGS1, SGMS2, SGMS1 | CYP2C9 2322/4885CYP2C19 2390/4885TDP1 3076/4885 |
| US-20050025732-A1 | Cosmetic preparations | MGLL, FFAR1, DAGLA | CYP2C9 1302/4885CYP2C19 1014/4885TDP1 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.